Cargando…
Novel Possible Protein Targets in Neovascular Age-Related Macular Degeneration: A Pilot Study Experiment
Age-related macular degeneration (AMD) is among the world's leading causes of blindness. In its neovascular form (nAMD), around 25% of patients present further anatomical and visual deterioration due to persistence of neovascular activity, despite gold-standard treatment protocols using intravi...
Autores principales: | Coronado, Bruno Nobre Lins, da Cunha, Felipe Bruno Santos, de Oliveira, Raphaela Menezes, Nóbrega, Otávio de Toledo, Ricart, Carlos André Ornelas, Fontes, Wagner, de Sousa, Marcelo Valle, de Ávila, Marcos Pereira, Martins, Aline Maria Araújo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828634/ https://www.ncbi.nlm.nih.gov/pubmed/35155457 http://dx.doi.org/10.3389/fmed.2021.692272 |
Ejemplares similares
-
Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma
por: de Oliveira, Raphaela Menezes, et al.
Publicado: (2018) -
Treatment of neovascular age-related macular degeneration in patients with diabetes
por: Cummings, Michael, et al.
Publicado: (2008) -
Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021) -
Color Fundus Autofluorescence to Determine Activity of Macular Neovascularization in Age-Related Macular Degeneration
por: Vujosevic, Stela, et al.
Publicado: (2021) -
Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)